Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$605.5m reported value +59.4% vs Q1 2020
63positions
55.6%in top 10
24 new 19 added 19 reduced 16 sold out vs Q1 2020

Options: 2 call positions ($7.6m notional), 4 put positions ($116.2m notional) – listed below, not included above.

Holdings, Q2 2020

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 954,738 $53.1m8.76% 8.76% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 954.7k
2 TG THERAPEUTICS INC COM TGTX TGTX 2,501,272 $48.7m8.05% 8.05% AddedShares held: Q4 2019 776.3k, Q1 2020 2.5m, Q2 2020 2.5m +40.1k +40,135 1.6%
3 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 4,786,101 $33.1m5.47% 5.47% AddedShares held: Q4 2019 915.6k, Q1 2020 3.5m, Q2 2020 4.8m +1.3m +1,282,039 36.6%
4 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 448,264 $32.8m5.41% 5.41% AddedShares held: Q4 2019 0, Q1 2020 106.4k, Q2 2020 448.3k +341.9k +341,879 321.4%
5 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 220,344 $32.6m5.38% 5.38% ReducedShares held: Q4 2019 202.9k, Q1 2020 275.5k, Q2 2020 220.3k -55.1k -55,150 -20.0%
6 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 562,151 $29.7m4.91% 4.91% AddedShares held: Q4 2019 140.6k, Q1 2020 352.6k, Q2 2020 562.2k +209.6k +209,600 59.5%
7 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 232,676 $28.2m4.65% 4.65% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 232.7k
8 ZOGENIX INC COM NEW ZGNX ZGNX 1,007,083 $27.2m4.49% 4.49% ReducedShares held: Q4 2019 495.6k, Q1 2020 2.0m, Q2 2020 1.0m -1.0m -1,006,384 -50.0%
9 HESKA CORP COM RESTRC NEW HSKA HSKA 280,256 $26.1m4.31% 4.31% AddedShares held: Q4 2019 20.8k, Q1 2020 20.8k, Q2 2020 280.3k +259.5k +259,485 1249.3%
10 DECIPHERA PHARMACEUTICALS IN COM DCPH DCPH 418,652 $25.0m4.13% 4.13% AddedShares held: Q4 2019 128.7k, Q1 2020 414.1k, Q2 2020 418.7k +4.6k +4,571 1.1%
11 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 4,847,792 $23.1m3.82% 3.82% ReducedShares held: Q4 2019 4.9m, Q1 2020 7.5m, Q2 2020 4.8m -2.7m -2,694,580 -35.7%
12 DANAHER CORPORATION COM DHR DHR 107,857 $19.1m3.15% 3.15% ReducedShares held: Q4 2019 197.1k, Q1 2020 234.0k, Q2 2020 107.9k -126.1k -126,100 -53.9%
13 FATE THERAPEUTICS INC COM FATE FATE 531,258 $18.2m3.01% 3.01% AddedShares held: Q4 2019 360.7k, Q1 2020 305.5k, Q2 2020 531.3k +225.8k +225,773 73.9%
14 ENSIGN GROUP INC COM ENSG ENSG 427,307 $17.9m2.96% 2.96% AddedShares held: Q4 2019 676.1k, Q1 2020 357.0k, Q2 2020 427.3k +70.3k +70,279 19.7%
15 MYOVANT SCIENCES LTD COM MYOV MYOV 760,551 $15.7m2.59% 2.59% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 760.6k
16 APELLIS PHARMACEUTICALS INC COM APLS APLS 420,932 $13.7m2.27% 2.27% ReducedShares held: Q4 2019 310.4k, Q1 2020 899.5k, Q2 2020 420.9k -478.5k -478,542 -53.2%
17 MODEL N INC COM MODN MODN 340,764 $11.8m1.96% 1.96% ReducedShares held: Q4 2019 207.6k, Q1 2020 374.3k, Q2 2020 340.8k -33.5k -33,520 -9.0%
18 SAREPTA THERAPEUTICS INC COM SRPT SRPT 71,731 $11.5m1.90% 1.90% NewShares held: Q4 2019 75.0k, Q1 2020 0, Q2 2020 71.7k
19 GLAXOSMITHKLINE PLC SPONSORED ADR SPONSORED ADR 227,263 $9.3m1.53% 1.53% ReducedShares held: Q4 2019 1.0m, Q1 2020 510.6k, Q2 2020 227.3k -283.3k -283,308 -55.5%
20 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 712,698 $9.3m1.53% 1.53% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 712.7k
21 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 548,325 $8.9m1.47% 1.47% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 548.3k
22 LIQUIDIA CORPORATION COM NEW LQDA LQDA 859,724 $7.2m1.20% 1.20% AddedShares held: Q4 2019 284.1k, Q1 2020 244.6k, Q2 2020 859.7k +615.1k +615,087 251.4%
23 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 105,169 $7.0m1.15% 1.15% AddedShares held: Q4 2019 5.0k, Q1 2020 76.5k, Q2 2020 105.2k +28.7k +28,710 37.5%
24 PACIRA BIOSCIENCES INC COM PCRX PCRX 132,655 $7.0m1.15% 1.15% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 132.7k
25 MYOKARDIA INC COM MYOK MYOK 70,594 $6.8m1.13% 1.13% AddedShares held: Q4 2019 21.5k, Q1 2020 27.8k, Q2 2020 70.6k +42.8k +42,842 154.4%
26 OXFORD IMMUNOTEC GLOBAL PLC ORD SHS OXFD OXFD 350,138 $4.6m0.75% 0.75% AddedShares held: Q4 2019 349.8k, Q1 2020 172.2k, Q2 2020 350.1k +177.9k +177,945 103.3%
27 AFFIMED N V COM COM 942,989 $4.4m0.72% 0.72% AddedShares held: Q4 2019 857.8k, Q1 2020 560.8k, Q2 2020 943.0k +382.2k +382,189 68.2%
28 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 886,587 $4.2m0.70% 0.70% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 886.6k
29 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 258,360 $4.1m0.68% 0.68% AddedShares held: Q4 2019 0, Q1 2020 210.0k, Q2 2020 258.4k +48.3k +48,347 23.0%
30 MOMENTA PHARMACEUTICALS INC COM MNTA MNTA 124,338 $4.1m0.68% 0.68% ReducedShares held: Q4 2019 0, Q1 2020 146.6k, Q2 2020 124.3k -22.2k -22,212 -15.2%
31 QIAGEN NV SHS NEW SHS NEW 82,466 $3.5m0.58% 0.58% NewShares held: Q4 2019 137.0k, Q1 2020 0, Q2 2020 82.5k
32 CYTOKINETICS INC COM NEW CYTK CYTK 141,700 $3.3m0.55% 0.55% ReducedShares held: Q4 2019 181.7k, Q1 2020 181.7k, Q2 2020 141.7k -40.0k -40,000 -22.0%
33 DICERNA PHARMACEUTICALS INC COM DRNA DRNA 128,905 $3.3m0.54% 0.54% AddedShares held: Q4 2019 18.7k, Q1 2020 59.8k, Q2 2020 128.9k +69.1k +69,131 115.7%
34 RADIUS HEALTH INC COM NEW RDUS RDUS 220,110 $3.0m0.50% 0.50% ReducedShares held: Q4 2019 318.8k, Q1 2020 301.1k, Q2 2020 220.1k -81.0k -80,963 -26.9%
35 HCA HEALTHCARE INC COM HCA HCA 30,400 $3.0m0.49% 0.49% ReducedShares held: Q4 2019 0, Q1 2020 101.0k, Q2 2020 30.4k -70.6k -70,600 -69.9%
36 VAPOTHERM INC COM COM 71,819 $2.9m0.49% 0.49% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 71.8k
37 DEXCOM INC COM DXCM DXCM 6,670 $2.7m0.45% 0.45% ReducedShares held: Q4 2019 12.1k, Q1 2020 19.5k, Q2 2020 6.7k -12.9k -12,867 -65.9%
38 BIODELIVERY SCIENCES INTL IN COM BDSI BDSI 583,504 $2.5m0.42% 0.42% AddedShares held: Q4 2019 335.5k, Q1 2020 122.7k, Q2 2020 583.5k +460.8k +460,802 375.6%
39 SANOFI SPONSORED ADR SNY SNY 49,778 $2.5m0.42% 0.42% ReducedShares held: Q4 2019 441.7k, Q1 2020 189.6k, Q2 2020 49.8k -139.8k -139,800 -73.7%
40 CHEMOCENTRYX INC COM CCXI CCXI 40,842 $2.4m0.39% 0.39% ReducedShares held: Q4 2019 513.2k, Q1 2020 580.0k, Q2 2020 40.8k -539.2k -539,169 -93.0%
41 CONCERT PHARMACEUTICALS INC COM CNCE CNCE 232,983 $2.3m0.38% 0.38% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 233.0k
42 PENNANT GROUP INC COM PNTG PNTG 102,568 $2.3m0.38% 0.38% ReducedShares held: Q4 2019 371.2k, Q1 2020 282.2k, Q2 2020 102.6k -179.6k -179,613 -63.6%
43 OTONOMY INC COM OTIC OTIC 601,163 $2.2m0.36% 0.36% AddedShares held: Q4 2019 550.7k, Q1 2020 561.7k, Q2 2020 601.2k +39.4k +39,426 7.0%
44 KINIKSA PHARMACEUTICALS LTD COM CL A COM CL A 81,700 $2.1m0.34% 0.34% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 81.7k
45 ALBIREO PHARMA INC COM BIOD BIOD 78,029 $2.1m0.34% 0.34% UnchangedShares held: Q4 2019 78.0k, Q1 2020 78.0k, Q2 2020 78.0k
46 STANDARD BIOTOOLS INC COM LAB LAB 467,923 $1.9m0.31% 0.31% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 467.9k
47 SCPHARMACEUTICALS INC COM SCPH SCPH 247,419 $1.8m0.30% 0.30% AddedShares held: Q4 2019 301.6k, Q1 2020 132.4k, Q2 2020 247.4k +115.0k +115,000 86.8%
48 PROTHENA CORP PLC SHS PRTA PRTA 152,213 $1.6m0.26% 0.26% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 152.2k
49 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 492,272 $1.5m0.24% 0.24% ReducedShares held: Q4 2019 580.4k, Q1 2020 580.4k, Q2 2020 492.3k -88.1k -88,078 -15.2%
50 CYCLERION THERAPEUTICS INC COM COM 247,663 $1.5m0.24% 0.24% ReducedShares held: Q4 2019 0, Q1 2020 337.1k, Q2 2020 247.7k -89.5k -89,482 -26.5%
51 ZYMEWORKS INC COM ZYME ZYME 40,000 $1.4m0.24% 0.24% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 40.0k
52 SESEN BIO INC COM COM 2,000,000 $1.4m0.24% 0.24% AddedShares held: Q4 2019 1.3m, Q1 2020 1.3m, Q2 2020 2.0m +700.0k +700,000 53.9%
53 PROTARA THERAPEUTICS INC COM STK TARA TARA 46,310 $1.4m0.22% 0.22% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 46.3k
54 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 64,056 $1.3m0.21% 0.21% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 64.1k
55 SOLID BIOSCIENCES INC COM COM 407,024 $1.2m0.20% 0.20% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 407.0k
56 KALVISTA PHARMACEUTICALS INC COM KALV KALV 89,806 $1.1m0.18% 0.18% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 89.8k
57 UNIQURE NV SHS QURE QURE 22,928 $1.0m0.17% 0.17% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 22.9k
58 DYNAVAX TECHNOLOGIES CORP COM NEW DVAX DVAX 97,800 $867.5k0.14% 0.14% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 97.8k
59 TELIGENT INC NEW COM NEW COM NEW 354,998 $859.1k0.14% 0.14% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 355.0k
60 BURNING ROCK BIOTECH LTD SPONSORED ADS SPONSORED ADS 30,000 $810.3k0.13% 0.13% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 30.0k
61 OSMOTICA PHARMACEUTICALS PLC SHS RVLPQ RVLPQ 79,037 $531.9k0.09% 0.09% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 79.0k
62 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 49,008 $470.5k0.08% 0.08% ReducedShares held: Q4 2019 69.7k, Q1 2020 69.7k, Q2 2020 49.0k -20.7k -20,700 -29.7%
63 IMMUNOVANT INC COM IMVT IMVT 12,266 $298.7k0.05% 0.05% ReducedShares held: Q4 2019 76.9k, Q1 2020 76.9k, Q2 2020 12.3k -64.6k -64,600 -84.0%

Sold out since Q1 2020

SecurityTickerShares held beforeValue then
KADMON HLDGS INC KDMN KDMN 975,350 $4.1m975.4k shares
ACCELERON PHARMA INC XLRN XLRN 42,305 $3.8m42.3k shares
IOVANCE BIOTHERAPEUTICS INC IOVA IOVA 90,047 $2.7m90.0k shares
GENMARK DIAGNOSTICS INC GNMK GNMK 524,257 $2.2m524.3k shares
ENVISTA HOLDINGS CORPORATION NVST NVST 109,212 $1.6m109.2k shares
AGILE THERAPEUTICS INC AGRX AGRX 711,756 $1.3m711.8k shares
TELIGENT INC NEW 3,862,903 $1.1m3.9m shares
XENON PHARMACEUTICALS INC XENE XENE 71,591 $811.8k71.6k shares
ARTARA THERAPEUTICS INC PRTO PRTO 32,478 $747.0k32.5k shares
INFLARX NV IFRX IFRX 195,488 $746.8k195.5k shares
AQUESTIVE THERAPEUTICS INC AQST AQST 300,000 $657.0k300.0k shares
IGM BIOSCIENCES INC IGMS IGMS 9,770 $548.6k9.8k shares
MACROGENICS INC MGNX MGNX 91,998 $535.4k92.0k shares
PUMA BIOTECHNOLOGY INC PBYI PBYI 58,251 $491.6k58.3k shares
EHEALTH INC EHTH EHTH 3,153 $444.0k3.2k shares
PFENEX INC PFNX PFNX 46,293 $408.3k46.3k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 340,000 $104.8m340.0k shares Added
SELECT SECTOR SPDR TR XLV · Put XLVPut 80,000 $8.0m80.0k shares New
AMARIN CORP PLC Call Call 1,080,300 $7.5m1.1m shares Added
ALIGN TECHNOLOGY INC ALGN · Put ALGNPut 10,000 $2.7m10.0k shares Unchanged
AIR LEASE CORP AL · Put ALPut 20,000 $585.8k20.0k shares Unchanged
ZOGENIX INC ZGNX · Call ZGNXCall 5,500 $148.6k5.5k shares Unchanged

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17